CSGCX
Price
$44.04
Change
-$0.14 (-0.32%)
Updated
Jul 11 closing price
Net Assets
1.42B
RLBGX
Price
$36.86
Change
-$0.12 (-0.32%)
Updated
Jul 11 closing price
Net Assets
252.03B
Interact to see
Advertisement

CSGCX vs RLBGX

Header iconCSGCX vs RLBGX Comparison
Open Charts CSGCX vs RLBGXBanner chart's image
Calvert Balanced C
Price$44.04
Change-$0.14 (-0.32%)
VolumeN/A
Net Assets1.42B
American Funds American Balanced R6
Price$36.86
Change-$0.12 (-0.32%)
VolumeN/A
Net Assets252.03B
CSGCX vs RLBGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSGCX vs. RLBGX commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 252B vs. CSGCX (1.42B). RLBGX pays higher dividends than CSGCX: RLBGX (2.15) vs CSGCX (0.66). CSGCX was incepted earlier than RLBGX: CSGCX (31 years) vs RLBGX (16 years). CSGCX (1.66) is less costly to investors than RLBGX (0.25). CSGCX is a more actively managed with annual turnover of: 153.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than CSGCX: RLBGX (250) vs CSGCX (1000). RLBGX annual gain was more profitable for investors over the last year : 7.17 vs. CSGCX (3.97). RLBGX return over 5 years is better than : 42.13 vs. CSGCX (32.45).
CSGCXRLBGXCSGCX / RLBGX
Total Expense Ratio1.660.25664%
Annual Report Gross Expense Ratio1.660.25664%
Fund Existence31 years16 years-
Gain YTD3.8848.14248%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B252B1%
Annual Yield % from dividends0.662.1531%
Returns for 1 year3.977.1755%
Returns for 3 years33.9437.3091%
Returns for 5 years32.4542.1377%
Returns for 10 years40.7666.2062%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMLX7.680.29
+3.92%
Amylyx Pharmaceuticals
OFS8.600.14
+1.65%
OFS Capital Corp
AEE96.20-0.09
-0.09%
Ameren Corp
ADNT22.73-0.14
-0.61%
Adient plc
IMNN0.61-0.05
-6.91%
Imunon